Quarterly report pursuant to Section 13 or 15(d)

Earnings Per Share (Tables)

v3.22.1
Earnings Per Share (Tables)
3 Months Ended
Mar. 31, 2022
Earnings Per Share [Abstract]  
Schedule of Earnings Per Share, Basic and Diluted
The following table presents the reconciliation of net loss used in computing diluted net loss per share of common stock:
Three Months Ended March 31,
2022 2021
Net loss $ (22,054,535) $ (120,506,771)
Interest on convertible notes —  2,000,000 
Change in fair value of convertible notes —  (15,500,000)
Adjusted net loss $ (22,054,535) $ (134,006,771)

The following table presents the reconciliation of basic to diluted weighted average shares used in computing net loss per share of common stock:

Three Months Ended March 31,
2022 2021
Weighted average shares outstanding, basic 151,939,491  122,633,856 
Stock-based awards and warrants —  — 
Convertible notes —  5,667,328 
Weighted average shares outstanding, diluted 151,939,491  128,301,184 
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share
The following table presents the potentially dilutive shares that were excluded from the computation of diluted net loss per share of common stock, because their effect was anti-dilutive:

Three Months Ended March 31,
2022 2021
Stock-based awards and warrants 6,525,999  3,929,451 
Convertible notes(1)
7,828,917  — 

(1) Represents shares issued in exchange of convertible notes on April 21, 2022. See Note 5, Debt, for additional information regarding shares issued subsequent to the date of the Condensed Consolidated Financial Statements.